Neuraxpharm appoints Tom Coogan as new Country Manager for Ireland

  • Europe’s leading central nervous system specialty company strengthens its management team in Ireland and reinforces its growth strategy

Dusseldorf and Barcelona, March 15, 2022 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), today announces that Tom Coogan has been appointed Country Manager for Ireland. The appointment reinforces Neuraxpharm’s management team in Ireland with an experienced executive who will focus on establishing Neuraxpharm as CNS specialist in the north-western European country.

Read more…